XJPX
9341
Market cap65mUSD
Jul 10, Last price
620.00JPY
1D
2.14%
1Q
6.71%
IPO
-65.63%
Name
Genova Inc
Chart & Performance
P/E
39.66
P/S
0.94
EPS
15.63
Div Yield, %
4.94%
Shrs. gr., 5y
0.69%
Rev. gr., 5y
25.14%
Revenues
11.57b
+15.59%
Net income
275m
-80.52%
CFO
54m
-95.49%
Dividend
Mar 30, 202630 JPY/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Operating within Japan, GENOVA, Inc. focuses on the digital healthcare market, providing both medical platform services and smart clinic solutions. Its offerings include Medical Doc, a comprehensive online platform that distributes diverse content, such as articles for healthcare institutions, patient experience narratives, treatment demonstrations, and general medical information. The company also developed Smart Clinic, an innovative telemedicine and consultation service that enables users to receive medical care from their homes or workplaces, bypassing the need for in-person hospital visits. Additionally, GENOVA offers a suite of clinic automation tools, including NOMOCa-Stand, a user-friendly automatic machine for reception and payments; NOMOCa-Regi, a dedicated self-pay terminal for clinic environments; and CLINIC BOT, an AI-driven chatbot system. GENOVA, Inc. was established in 2005 and is based in Tokyo, Japan.
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|
| 2026‑03 | 2025‑03 | 2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | |
| Income | ||||||
Revenues | ||||||
Cost of revenue | ||||||
Unusual Expense (Income) | ||||||
NOPBT | ||||||
NOPBT Margin | ||||||
Operating Taxes | ||||||
Tax Rate | ||||||
NOPAT | ||||||
Net income | ||||||
Dividends | ||||||
Dividend yield | ||||||
Proceeds from repurchase of equity | ||||||
BB yield | ||||||
| Debt | ||||||
Debt current | ||||||
Long-term debt | ||||||
Deferred revenue | ||||||
Other long-term liabilities | ||||||
Net debt | ||||||
| Cash flow | ||||||
Cash from operating activities | ||||||
CAPEX | ||||||
Cash from investing activities | ||||||
Cash from financing activities | ||||||
FCF | ||||||
| Balance | ||||||
Cash | ||||||
Long term investments | ||||||
Excess cash | ||||||
Stockholders' equity | ||||||
Invested Capital | ||||||
ROIC | ||||||
ROCE | ||||||
| EV | ||||||
Common stock shares outstanding | ||||||
Price | ||||||
Market cap | ||||||
EV | ||||||
EBITDA | ||||||
EV/EBITDA | ||||||
Interest | ||||||
Interest/NOPBT | ||||||